[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]




Скачать 217.57 Kb.
Название[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]
страница4/8
Дата15.10.2012
Размер217.57 Kb.
ТипДокументы
1   2   3   4   5   6   7   8
Int J Oncol 26 (6): 1691-1697, 2005

Huygens A; Kamuhabwa AR; Van Cleynenbreugel B; Van Poppel H; Roskams T; de Witte PA. In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder. BJU Int 95 (3): 436-441, 2005

Ichikawa K; Hikita T; Maeda N; Yonezawa S; Takeuchi Y; Asai T; Namba Y; Oku N. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochim Biophys Acta 1669 (1): 69-74, 2005

Ishii K; Takayanagi A; Shimizu S; Abe H; Sogawa K; Kobayashi N. In vitro photodynamic effects of phthalocyaninatosilicon covalently linked to 2,2,6,6-tetramethyl-1-piperidinyloxy radicals on cancer cells. Free Radic Biol Med 38 (7): 920-927, 2005

Jager HR; Taylor MN; Theodossy T; Hopper C. MR imaging-guided interstitial photodynamic laser therapy for advanced head and neck tumors. AJNR Am J Neuroradiol 26 (5): 1193-1200, 2005

Jain S; Kockelbergh RC. The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer. BJU Int 96 (1): 17-21, 2005

Jakobs R; Weickert U; Hartmann D; Riemann JF. [Interventional endoscopy for benign and malignant bile duct strictures]. Z Gastroenterol 43 (3): 295-303, 2005

Jakus J; Farkas O. Photosensitizers and antioxidants: a way to new drugs? Photochem Photobiol Sci 4 (9): 694-698, 2005

Jang WD; Nishiyama N; Zhang GD; Harada A; Jiang DL; Kawauchi S; Morimoto Y; Kikuchi M; Koyama H; Aida T; Kataoka K. Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy. Angew Chem Int Ed Engl 44 (3): 419-423, 2005

Jang YP; Zhou J; Nakanishi K; Sparrow JR. Anthocyanins protect against A2E photooxidation and membrane permeabilization in retinal pigment epithelial cells. Photochem Photobiol 81 (3): 529-536, 2005

Jankun J; Keck RW; Skrzypczak-Jankun E; Lilge L; Selman SH. Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy. BJU Int 95 (9): 1237-1244, 2005

Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; Konig F; Knuchel R; Kurth KH. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 174 (3): 862-866, 2005

Johnston MH. Technology insight: ablative techniques for Barrett's esophagus--current and emerging trends. Nat Clin Pract Gastroenterol Hepatol 2 (7): 323-330, 2005

Johnston MH. Technology insight: ablative techniques for Barrett's esophagus--current and emerging trends. Nat Clin Pract Oncol 2 (8): 323-330, 2005

Jonas JB; Kreissig I; Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 24 (5): 587-611, 2005

Joyce AM; Kochman ML. Update on biliary endoscopy. Curr Opin Gastroenterol 21 (3): 354-358, 2005

Jung M. [Mucosectomy as sufficient therapy for early squamous cell.]. Chirurg 76 (11): 1018-1024, 2005

Jung S; Back K. Herbicidal and antioxidant responses of transgenic rice overexpressing Myxococcus xanthus protoporphyrinogen oxidase. Plant Physiol Biochem 43 (5): 423-430, 2005

Jurklies B; Bornfeld N. The role of photodynamic therapy in the treatment of symptomatic choroidal hemangioma. Graefes Arch Clin Exp Ophthalmol 243 (5): 393-396, 2005

Kamp H; Tietz HJ; Lutz M; Piazena H; Sowyrda P; Lademann J; Blume-Peytavi U. Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses 48 (2): 101-107, 2005

Kamuhabwa AA; Di Mavungu JD; Baert L; D'Hallewin MA; Hoogmartens J; de Witte PA. Determination of hypericin in human plasma by high-performance liquid chromatography after intravesical administration in patients with transitional cell carcinoma of the bladder. Eur J Pharm Biopharm 59 (3): 469-474, 2005

Kapsokalyvas D; Dimitriou H; Skalkos D; Konstantoudakis G; Filippidis G; Stiakaki E; Papazoglou T; Kalmanti M. Does Hypericum perforatum L. extract show any specificity as photosensitizer for HL-60 leukemic cells and cord blood hemopoietic progenitors during photodynamic therapy? J Photochem Photobiol B 80 (3): 208-216, 2005

Karmakova T; Feofanov A; Pankratov A; Kazachkina N; Nazarova A; Yakubovskaya R; Lebedeva V; Ruziyev R; Mironov A; Maurizot JC; Vigny P. Tissue distribution and in vivo photosensitizing activity of 13,15-[N-(3-hydroxypropyl)]cycloimide chlorin p6 and 13,15-(N-methoxy)cycloimide chlorin p6 methyl ester. J Photochem Photobiol B , 2005

Kaviani A; Ataie-Fashtami L; Fateh M; Sheikhbahaee N; Ghodsi M; Zand N; Djavid GE. Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features. Lasers Surg Med 36 (5): 377-382, 2005

Kelly KM; Choi B; McFarlane S; Motosue A; Jung B; Khan MH; Ramirez-San-Juan JC; Nelson JS. Description and analysis of treatments for port-wine stain birthmarks. Arch Facial Plast Surg 7 (5): 287-294, 2005

Kessel D; Castelli M; Reiners JJ. Ruthenium red-mediated suppression of Bcl-2 loss and Ca(2+) release initiated by photodamage to the endoplasmic reticulum: scavenging of reactive oxygen species. Cell Death Differ 12 (5): 502-511, 2005

Khan SA; Thomas HC; Davidson BR; Taylor-Robinson SD. Cholangiocarcinoma. Lancet 366 (9493): 1303-1314, 2005

Kiesslich T; Plaetzer K; Oberdanner CB; Berlanda J; Obermair FJ; Krammer B. Differential effects of glucose deprivation on the cellular sensitivity towards photodynamic treatment-based production of reactive oxygen species and apoptosis-induction. FEBS Lett 579 (1): 185-190, 2005

Kim HS; Yoo JY; Cho KH; Kwon OS; Moon SE. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: clinical and histopathologic evaluation. Dermatol Surg 31 (1): 33-36, 2005

Kinge B; Syrdalen P; Bjornsson OM. Photodynamic therapy for choroidal neovascularization secondary to sympathetic ophthalmia. Retina 25 (3): 375-377, 2005

Klais CM; Ober MD; Freund KB; Ginsburg LH; Luckie A; Mauget-Faysse M; Coscas G; Gross NE; Yannuzzi LA. Choroidal infarction following photodynamic therapy with verteporfin. Arch Ophthalmol 123 (8): 1149-1153, 2005

Koba M; Konopa J. [Actinomycin D and its mechanisms of action]. Postepy Hig Med Dosw (Online ) 59: 290-298, 2005

Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H. Photodynamic therapy with mono-l-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: Experimental study on an animal model of nude mouse. Oral Oncol , 2005

Kogan BY. Nonlinear photodynamic therapy. Method of pulsed oxygen depletion. Photochem Photobiol Sci 4 (11): 903-906, 2005

Kolarova H; Macecek J; Nevrelova P; Huf M; Tomecka M; Bajgar R; Mosinger J; Strnad M. Photodynamic therapy with zinc-tetra(p-sulfophenyl)porphyrin bound to cyclodextrin induces single strand breaks of cellular DNA in G361 melanoma cells. Toxicol In Vitro 19 (7): 971-974, 2005

Kondo K; Miyoshi T; Takizawa H; Kenzaki K; Sakiyama S; Tangoku A. Photodynamic therapy for submucosal tumor of the central bronchus. J Med Invest 52 (3-4): 208-211, 2005

Korbelik M; Sun J. Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol Immunother : 1-10, 2005

Korbelik M; Sun J; Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 65 (3): 1018-1026, 2005

Kosaka S; Kawana S; Zouboulis CC; Hasan T; Ortel B. Targeting of Sebocytes by Aminolevulinic Acid-dependent Photosensitization. Photochem Photobiol , 2005

Kosobe T; Moriyama E; Tokuoka Y; Kawashima N. Size and surface charge effect of 5-aminolevulinic acid-containing liposomes on photodynamic therapy for cultivated cancer cells. Drug Dev Ind Pharm 31 (7): 623-629, 2005

Kostenich G; Kimel S; Peled S; Orenstein A. Monitoring PDT-induced damage using spectrally resolved reflectance imaging of tissue oxygenation. Cancer Lett 219 (2): 169-175, 2005

Kostova I. Lanthanides as anticancer agents. Curr Med Chem Anti -Canc Agents 5 (6): 591-602, 2005

Kotoula MG; Tsironi EE; Karabatsas CH; Chatzoulis DZ. Photodynamic therapy. Retina 25 (1): 102-103, 2005

Krebs I; Binder S; Stolba U; Glittenberg C; Brannath W; Goll A. Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy. Am J Ophthalmol 140 (3): 416-425, 2005

Krebs I; Binder S; Stolba U; Schmid K; Glittenberg C; Brannath W; Goll A. Optical coherence tomography guided retreatment of photodynamic therapy. Br J Ophthalmol 89 (9): 1184-1187, 2005

Kriska T; Korytowski W; Girotti AW. Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells. Arch Biochem Biophys 433 (2): 435-446, 2005

Kristiansson S; Juzeniene A; Juzenas P; Iani V; Lofgren L; Moan J. Kinetics of protoporphyrin IX formation in rat oral mucosa and skin after application of 5-aminolevulinic acid and its methylester. Photochem Photobiol 81 (2): 394-397, 2005

Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats. Lasers Surg Med 37 (4): 271-277, 2005

Krummenauer F; Braun M; Dick HB. Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration. Eur J Ophthalmol 15 (1): 74-80, 2005

Kubin A; Wierrani F; Burner U; Alth G; Grunberger W. Hypericin--the facts about a controversial agent. Curr Pharm Des 11 (2): 233-253, 2005

Kubler A; Niziol C; Sidhu M; Dunne A; Werner JA. [In Process Citation]. Laryngorhinootologie 84 (10): 725-732, 2005

Kusuzaki K; Murata H; Matsubara T; Miyazaki S; Shintani K; Seto M; Matsumine A; Hosoi H; Sugimoto T; Uchida A. Clinical outcome of a novel photodynamic therapy technique using acridine orange for synovial sarcomas. Photochem Photobiol 81 (3): 705-709, 2005

Kusuzaki K; Murata H; Matsubara T; Miyazaki S; Okamura A; Seto M; Matsumine A; Hosoi H; Sugimoto T; Uchida A. Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas. Anticancer Res 25 (2B): 1225-1235, 2005

Kvacheva ZB; Lobanok ES; Votiakov VI; Shukanova NA; Vorobei AV; Nikolaeva SN; Titov LP. [Photodynamic inhibition of infection caused by herpes simplex virus type 1 in the cultured cells, by using 5-aminolevulinic acid-induced porphyrins]. Vopr Virusol 50 (4): 44-47, 2005

Kwitniewski M; Kunikowska D; Dera-Tomaszewska B; Tokarska-Pietrzak E; Dziadziuszko H; Graczyk A; Glosnicka R. Influence of diamino acid derivatives of protoporphyrin IX on mouse immunological system: Preliminary results. J Photochem Photobiol B 81 (3): 129-135, 2005

Kyagova AA; Mansurova GV; Kozir LA; Ponomarev GV; Pavlov VY; Konstantinov IO; Potapenko AY. Systemic Suppression of Contact Hypersensitivity by Products of Protoporphyrin IX Photooxidation. Photochem Photobiol , 2005

Ladas ID; Georgalas I; Rouvas AA; Gotsis S; Karagiannis DA; Moschos M. Photodynamic therapy with verteporfin of choroidal neovascularization in angioid streaks: conventional versus early retreatment. Eur J Ophthalmol 15 (1): 69-73, 2005

Lagoda TS; Kaplan MA; Bondar' MB; Bokova MB; Ivanov EA; Broin AI; Spichenkova ON. [Use of photosense treatment to enhance photodynamic effect on solid sarcoma-1 in Wistar rats]. Vopr Onkol 51 (1): 103-107, 2005

Lai CC; Wu WC; Chuang LH; Yeung L; Wei W; Yang KJ. Quantitative grading of preretinal neovascularization in adult rats. Acta Ophthalmol Scand 83 (5): 590-594, 2005

Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series. Eye 19 (8): 834-840, 2005

Lambrechts SA; Aalders MC; Verbraak FD; Lagerberg JW; Dankert JB; Schuitmaker JJ. Effect of albumin on the photodynamic inactivation of microorganisms by a cationic porphyrin. J Photochem Photobiol B 79 (1): 51-57, 2005

Lambrechts SA; Aalders MC; Van Marle J. Mechanistic study of the photodynamic inactivation of Candida albicans by a cationic porphyrin. Antimicrob Agents Chemother 49 (5): 2026-2034, 2005

Lambrechts SA; Schwartz KR; Aalders MC; Dankert JB. Photodynamic inactivation of fibroblasts by a cationic porphyrin. Lasers Med Sci 20 (2): 62-67, 2005

Lambrechts SA; Demidova TN; Aalders MC; Hasan T; Hamblin MR. Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci 4 (7): 503-509, 2005

Larko O. Photodynamic diagnosis of non-melanoma skin cancer. Australas J Dermatol 46 Suppl: S26, 2005

Larko O. Photodynamic therapy. Australas J Dermatol 46 Suppl: S1-S2, 2005

Larsson J; Gillies MC. Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration. Clin Experiment Ophthalmol 33 (5): 544-545, 2005

Lassalle HP; Lourette N; Maunit B; Muller JF; Guillemin F; Bezdetnaya-Bolotine L. MALDI-TOF mass spectrometric analysis for the characterization of the 5,10,15,20-tetrakis- (m-hydroxyphenyl)bacteriochlorin (m-THPBC) photoproducts in biological environment. J Mass Spectrom 40 (9): 1149-1156, 2005

Le NT; Chen BJ; Chao NJ. Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting. Cytotherapy 7 (2): 126-133, 2005

Lee HB; Ho AS; Teo SH. p53 Status does not affect photodynamic cell killing induced by hypericin. Cancer Chemother Pharmacol : 1-8, 2005

Lee MR; Ryman W. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Australas J Dermatol 46 (3): 196-198, 2005

Leslie T; Lois N; Christopoulou D; Olson JA; Forrester JV. Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol 89 (2): 147-150, 2005

Levy J; Shneck M; Klemperer I; Lifshitz T. Treatment of subfoveal choroidal neovascularization secondary to choroidal nevus using photodynamic therapy. Ophthalmic Surg Lasers Imaging 36 (4): 343-345, 2005

Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Bioconjug Chem 16 (1): 32-42, 2005

Li H; Marotta DE; Kim S; Busch TM; Wileyto EP; Zheng G. High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles. J Biomed Opt 10 (4): 41203, 2005

Li Q; Chang CK; Huie CW. Microemulsion and micellar electrokinetic chromatography of Hematoporphyrin D: a starting material of hematoporphyrin derivative.
1   2   3   4   5   6   7   8

Похожие:

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSelected Anomalies and Diseases of the Eye

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconHepatic Liver Diseases – Methods for Diagnosis and

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconAbengoechea-hernandez, S., Elizalde-montagut, J. & Fideliz de la paz-dalisay, M. (2007) [Photodynamic therapy in adult-onset foveomacular vitelliform

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconБад «нагипол» в терапии алиментарно-зависимых патологий. Baa "nagipol" in therapy alimentary-dependent’s diseases
Ключевые слова: биологически-активная добавка (бад), пивные дрожжи, автолизат, алиментарно-зависимые патологии, витамины, аминокислоты,...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEndometriosis. Gynaecological diseases of children and teenagers
...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSession 2: Fourier Transform Infrared (ft ir) & Fluorescence Spectroscopy

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconThe American Occupational Therapy Foundation & American Occupational Therapy Association’s

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon2. Device choice

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon“Assistive Device for Calendar Production”

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEye Tracking and e-Learning

Разместите кнопку на своём сайте:
Библиотека


База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Библиотека
Главная страница